Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.
Press releases published on April 24, 2025
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
GlobeNewswire
·
April 24, 2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through the …
Imprivata Names Joel Burleson-Davis as Chief Technology Officer
GlobeNewswire
·
April 24, 2025
WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for life- and mission-critical industries, today announced the appointment of Joel Burleson-Davis to Chief Technology Officer (CTO). Serving most recently as SVP of …
Healing with Data: Transforming Pediatric Care at Leading Maternal and Children’s Hospital Sant Joan de Déu
GlobeNewswire
·
April 24, 2025
Leading Spanish hospital Relies on Denodo Platform for Real-time patient data monitoring and AI-driven analytics, updating data every 30 seconds PALO ALTO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that …
Dig In! Moley Leads the Charge for Global Action Days
GlobeNewswire
·
April 24, 2025
London, April 24, 2025 (GLOBE NEWSWIRE) -- Get ready to stomp, soak, drum and dance — because Global Action Days has officially begun, and it’s all happening beneath our feet! Kicking off on Earth Day and continuing for two action-packed weeks, the …
Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight
GlobeNewswire
·
April 24, 2025
New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight The neuroprosthetics market is experiencing significant …
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire
·
April 24, 2025
New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sarcopenia market remains largely untapped, with significant …
Guerbet: Q1 2025 revenue
GlobeNewswire
·
April 24, 2025
Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER1 and on a like-for-like basis2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum in Diagnostic Imaging (-8.7% at CER …
GUERBET: Chiffre d’affaires du 1er trimestre 2025
GlobeNewswire
·
April 24, 2025
Chiffre d’affaires du 1er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC1 et périmètre comparable2 Comme anticipé, un premier trimestre marqué par un impact France persistant et un effet de base pénalisant Une …
Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com), société leader et innovante dans le domaine du traitement des maladies de la prostate, a annoncé ce jour un nouveau …
Best Dental Implants in Seattle Done by Dr. Javadi
GlobeNewswire
·
April 24, 2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics …
OBI Pharma kündigt Posterpräsentationen auf der AACR-Jahrestagung 2025 zu den Antikörper-Wirkstoff-Konjugaten (AWK) OBI-992 und OBI-902, den ADC-Enabling-Technologien GlycOBI® und ThiOBI®, dem Prodrug OBI-3424 und der Globo-H-Forschung (GH-Forschung) a…
GlobeNewswire
·
April 24, 2025
TAIPEH, Taiwan, April 24, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO), hat heute nichtklinische Daten zu OBI-902 bekannt gegeben, einem potenziell in seiner Klasse führenden Anti-TROP2-AWK, das mithilfe der firmeneigenen GlycOBI®- …
OBI Pharma annonce l’exposition d’affiches au congrès annuel de l’AACR 2025 concernant les conjugués anticorps-médicaments (CAM) OBI-992 et OBI-902, les technologies habilitantes relatives aux CAM GlycOBI® et ThiOBI®, le promédicament OBI-3424 et la sc…
GlobeNewswire
·
April 24, 2025
TAIPEI, Taïwan, 24 avr. 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx : 4174. TWO) a communiqué aujourd’hui des données non cliniques sur OBI-902, un CAM anti-TROP2 potentiellement le meilleur de sa catégorie, développé à l’aide de la nouvelle génération …
Koelis Announces Partnership with Bot Image™ at AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France and PRINCETON, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in prostate care, announced today a new partnership with Bot Image™ (Omaha, NE, USA) to serve the …
Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research
GlobeNewswire
·
April 24, 2025
SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today announced the launch of Qdata® Cataracts, the most comprehensive …
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
GlobeNewswire
·
April 24, 2025
WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Socially Determined, a social risk analytics and solutions company leading the integration of health and social care, and Acentra Health, a technology and health solutions and services company dedicated to …
American Kidney Fund Announces 2025 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
GlobeNewswire
·
April 24, 2025
ROCKVILLE, Md., April 24, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announces its 2025 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program. Corporate Members provide vital support to AKF’s …
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
GlobeNewswire
·
April 24, 2025
Company Changes Corporate Name to Align with its AI Products and Core Vision Knoxville, TN, April 24, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, today …
The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025
GlobeNewswire
·
April 24, 2025
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced the Fourth Annual Liam Johnson Memorial Golf Outing …
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
April 24, 2025
– Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Advancing rapid clinical development plan for rademikibart; expect to initiate parallel Phase 2 trials in …
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
GlobeNewswire
·
April 24, 2025
SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, …